Avoid common mistakes on your manuscript.
Correction to: Childs Nerv Syst. 2023 Jun 21. https://doi.org/10.1007/s00381-023-06029-5. Epub ahead of print. PMID: 37344677
In the discussion section of this article we referred to a recent case report that had allegedly demonstrated development of a MPNST during on-going selumetinib therapy. We would like to clarify that the patients described in the cited case report were not on selumetinib therapy but were treated with trametinib. However, this does not change our conclusion that MEK inhibition in general might not be sufficient to prevent malignancy in NF1-PN.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rosenbaum, T., Vaassen, P. Correction to: A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy. Childs Nerv Syst 39, 3305 (2023). https://doi.org/10.1007/s00381-023-06106-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-023-06106-9